Mauro Schechter

6.4k total citations · 2 hit papers
62 papers, 3.9k citations indexed

About

Mauro Schechter is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mauro Schechter has authored 62 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Infectious Diseases, 27 papers in Virology and 23 papers in Epidemiology. Recurrent topics in Mauro Schechter's work include HIV/AIDS Research and Interventions (46 papers), HIV Research and Treatment (27 papers) and HIV/AIDS drug development and treatment (23 papers). Mauro Schechter is often cited by papers focused on HIV/AIDS Research and Interventions (46 papers), HIV Research and Treatment (27 papers) and HIV/AIDS drug development and treatment (23 papers). Mauro Schechter collaborates with scholars based in Brazil, United States and South Africa. Mauro Schechter's co-authors include Jean B. Nachega, Esper G. Kallás, David A. Cooper, David V. Glidden, Robert M. Grant, Albert Liu, Lee H. Harrison, Linda‐Gail Bekker, Juan V. Guanira and Kenneth H. Mayer and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Mauro Schechter

61 papers receiving 3.8k citations

Hit Papers

Antiretroviral Therapy in Adults 2000 2026 2008 2017 2000 2012 250 500 750

Peers

Mauro Schechter
Mark Dybul United States
Richard Marlink United States
Kholoud Porter United Kingdom
Ibou Thior United States
James Balsley United States
Philip Keiser United States
Mark Dybul United States
Mauro Schechter
Citations per year, relative to Mauro Schechter Mauro Schechter (= 1×) peers Mark Dybul

Countries citing papers authored by Mauro Schechter

Since Specialization
Citations

This map shows the geographic impact of Mauro Schechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Schechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Schechter more than expected).

Fields of papers citing papers by Mauro Schechter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauro Schechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Schechter. The network helps show where Mauro Schechter may publish in the future.

Co-authorship network of co-authors of Mauro Schechter

This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Schechter. A scholar is included among the top collaborators of Mauro Schechter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauro Schechter. Mauro Schechter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunter, James, Cibele Marli Cação Paiva Gouvêa, Élcio Leal, et al.. (2024). T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess. BMC Infectious Diseases. 24(1). 612–612. 2 indexed citations
2.
Diaz, Ricardo Sobhie, et al.. (2023). Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil. BMC Infectious Diseases. 23(1). 347–347. 16 indexed citations
3.
Janes, Holly, Marshall Brown, David V. Glidden, et al.. (2019). Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors. PLoS ONE. 14(9). e0222183–e0222183. 1 indexed citations
4.
Spinelli, Matthew A., David V. Glidden, Peter L. Anderson, et al.. (2019). Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project. AIDS Research and Human Retroviruses. 35(9). 788–793. 10 indexed citations
5.
Molina, Jean‐Michel, Birgit Grund, Fred M. Gordin, et al.. (2018). Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. The Lancet HIV. 5(4). e172–e180. 23 indexed citations
6.
Gandhi, Monica, David V. Glidden, Kenneth H. Mayer, et al.. (2016). Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study. The Lancet HIV. 3(11). e521–e528. 60 indexed citations
7.
Liu, Albert, David V. Glidden, Peter L. Anderson, et al.. (2014). Patterns and Correlates of PrEP Drug Detection Among MSM and Transgender Women in the Global iPrEx Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(5). 528–537. 57 indexed citations
8.
Fink, Valeria, Bryan E. Shepherd, Carina César, et al.. (2011). Cancer in HIV-Infected Persons From the Caribbean, Central and South America. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(5). 467–473. 15 indexed citations
9.
Nunes, Estêvão Portela, Beatriz Grinsztejn, & Mauro Schechter. (2011). The DART Trial: 'The Doctor's Dilemma' revisited. Journal of Antimicrobial Chemotherapy. 66(5). 964–967. 2 indexed citations
10.
Pacheco, Antônio Guilherme, Valéria Saraceni, Suely Tuboi, et al.. (2010). Estimating the Extent of Underreporting of Mortality Among HIV-Infected Individuals in Rio de Janeiro, Brazil. AIDS Research and Human Retroviruses. 27(1). 25–28. 17 indexed citations
11.
Tassie, Jean-Michel, Karen Malateste, Mar Pujades‐Rodríguez, et al.. (2010). Evaluation of Three Sampling Methods to Monitor Outcomes of Antiretroviral Treatment Programmes in Low- and Middle-Income Countries. PLoS ONE. 5(11). e13899–e13899. 11 indexed citations
12.
Hosseinipour, Mina C. & Mauro Schechter. (2010). Monitoring Antiretroviral Therapy in Resource-Limited Settings: Balancing Clinical Care, Technology, and Human Resources. Current HIV/AIDS Reports. 7(3). 168–174. 13 indexed citations
13.
Tuboi, Suely, Antônio Guilherme Pacheco, Lee H. Harrison, et al.. (2009). Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(1). 70–77. 36 indexed citations
14.
Keiser, Olivia, Patrick MacPhail, Andrew Boulle, et al.. (2009). Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy. Tropical Medicine & International Health. 14(10). 1220–1225. 66 indexed citations
15.
Nachega, Jean B., Edward J. Mills, & Mauro Schechter. (2009). Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Current Opinion in HIV and AIDS. 5(1). 70–77. 113 indexed citations
16.
McGowan, Catherine C., Pedro Cahn, Eduardo Gotuzzo, et al.. (2007). Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. International Journal of Epidemiology. 36(5). 969–976. 90 indexed citations
17.
Schechter, Mauro. (2007). Treatment at scale in Brazil: a physician's perspective. AIDS. 21(Suppl 4). S31–S35. 9 indexed citations
18.
Barroso, Paulo Feijó, et al.. (2003). Adherence to Antiretroviral Therapy and Persistence of HIV RNA in Semen. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(4). 435–440. 41 indexed citations
19.
Schechter, Mauro. (2002). HIV vaccine evaluation center in Rio de Janeiro, Brazil. Vaccine. 20(15). 1909–1911. 6 indexed citations
20.
Carpenter, Charles C. J., David A. Cooper, Margaret A. Fischl, et al.. (2000). Antiretroviral Therapy in Adults. JAMA. 283(3). 381–381. 874 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026